Results 151 to 160 of about 47,115 (244)

Association Between Systemic Immune‐Inflammation Index and Thyroid Function: A Cross‐Sectional Population‐Based Study

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background The systemic immune‐inflammation index (SII), an emerging inflammatory biomarker, has been associated with various diseases, but its relationship with thyroid function remains unclear. Our study aimed to investigate the potential connections between SII and thyroid function in the U.S. population. Methods We conducted a cross‐sectional study
Jiaqi Huang   +4 more
wiley   +1 more source

Study of Iodine Content in Commercial Salt of Nepal: Examining Compliance With Regulation, Associated Hazards, and Health Effects

open access: yesInternational Journal of Food Science, Volume 2026, Issue 1, 2026.
Iodine is a vital micronutrient necessary for thyroid hormone synthesis, growth, and neurodevelopment. Universal salt iodization was implemented globally, including in Nepal, to address the burden of iodine deficiency diseases. Despite the success, iodine loss from iodized salt due to temperature and storage practices remains an issue.
Yugesh Paudel   +4 more
wiley   +1 more source

FT3 Levels and Systemic Inflammation: Evidence From a Population‐Based NHANES Analysis

open access: yesMediators of Inflammation, Volume 2026, Issue 1, 2026.
Objective Previous studies suggest a complex interaction between 3,3′,5‐triiodo‐L‐thyronine (T3) and inflammation, but this relationship remains unclear. This study investigates the association between free triiodothyronine (FT3) levels and inflammatory markers in the US population using National Health and Nutrition Examination Survey (NHANES) data ...
Liu Yang   +7 more
wiley   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu   +56 more
wiley   +1 more source

SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page e5-e7, January 2026.
Ziad Reguiai   +8 more
wiley   +1 more source

[Autoimmune thyroiditis].

open access: yesActa medica portuguesa, 2007
The term autoimmune thyroiditis encompasses a group of high prevalence thyroid disorders, which have been classified in different ways throughout the years. In this article some aspects related to its classification, epidemiology, susceptibility factors, pathogenesis, histology, diagnosis and treatment are reviewed.
openaire   +1 more source

Home - About - Disclaimer - Privacy